Osaic Holdings’s HOOKIPA Pharma HOOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-513
| Closed | -$466 | – | 7987 |
|
|
2025
Q3 | $466 | Buy |
513
+13
| +3% | +$14 | ﹤0.01% | 7555 |
|
|
2025
Q2 | $625 | Sell |
500
-50
| -9% | -$62 | ﹤0.01% | 7300 |
|
|
2025
Q1 | $594 | Buy |
+550
| New | +$906 | ﹤0.01% | 6957 |
|
|
2024
Q3 | – | Sell |
-415
| Closed | -$2.46K | – | 7473 |
|
|
2024
Q2 | $2.46K | Buy |
415
+15
| +4% | +$119 | ﹤0.01% | 6513 |
|
|
2024
Q1 | $2.85K | Hold |
400
| – | – | ﹤0.01% | 6328 |
|
|
2023
Q4 | $3.24K | Buy |
+400
| New | +$2.2K | ﹤0.01% | 6350 |
|
|
2023
Q2 | – | Sell |
-201
| Closed | -$1.48K | – | 7507 |
|
|
2023
Q1 | $1.48K | Buy |
201
+74
| +58% | +$663 | ﹤0.01% | 6836 |
|
|
2022
Q4 | $1K | Buy |
127
+112
| +747% | +$1.21K | ﹤0.01% | 6885 |
|
|
2022
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 7362 |
|
|
2022
Q2 | $0 | Sell |
15
-40
| -73% | -$662 | ﹤0.01% | 7452 |
|
|
2022
Q1 | $1K | Buy |
55
+7
| +15% | +$125 | ﹤0.01% | 7050 |
|
|
2021
Q4 | $1K | Buy |
48
+8
| +20% | +$322 | ﹤0.01% | 7190 |
|
|
2021
Q3 | $2K | Hold |
40
| – | – | ﹤0.01% | 6855 |
|
|
2021
Q2 | $4K | Hold |
40
| – | – | ﹤0.01% | 6481 |
|
|
2021
Q1 | $5K | Buy |
+40
| New | +$4.83K | ﹤0.01% | 6148 |
|
Osaic Holdings's HOOK Position: Q4 2025 in Review
Osaic Holdings sold out of HOOKIPA Pharma (HOOK) in Q4 2025, closing a stake of 513 shares — an estimated $466 sold.
Osaic Holdings first reported a position in HOOK in Q1 2021 and held it in 15 quarters. The position peaked at $5K in Q1 2021. 0 funds tracked by Wall St. Rank hold HOOK as of Q4 2025.
- Osaic Holdings reported no remaining HOOKIPA Pharma position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 513 HOOKIPA Pharma shares in Q4 2025, an estimated $466.
- Osaic Holdings first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 15 quarters.
- Osaic Holdings's HOOKIPA Pharma position peaked at $5K in Q1 2021.
- 0 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.